Faculty
 |
Ronald L. Dalman, MD |
|
 |
Fritz R. Bech , MD |
|
 |
E. John Harris, MD |
|
 |
Jason T. Lee, MD |
|
 |
Cornelius Olcott, IV, MD |
|
 |
Christoper K. Zarins, MD |
|
 |
Wei Zhou, MD |
|
The faculty is distinguished by expertise in many aspects of vascular disease management, but perhaps none more so than aortic aneurysm disease. Stanford Vascular Surgeons are recognized around the world as leaders in aortic aneurysm treatment and research. Dr. Ronald Dalman is the Director and Principal Investigator of Stanford’s National Institutes of Heath (NIH) Specialized Center of Clinically Oriented Research (SCCOR) Program Project Grant focused on identifying novel treatment strategies and biomarkers for early aortic aneurysm disease. Dr. Christopher Zarins also serves as Principal Investigator on NIH grants focused on aortic disease and is widely recognized for his early and substantial contributions to the development of minimally invasive treatment solutions for abdominal and thoracic aneurysms. Vascular Center members R. Scott Mitchell MD and D. Craig Miller MD have extensive experience in the management of complex thoracic and thoracoabdominal aortic aneurysms, as well as aortic dissections and related major aortic diseases including Marfan’s Syndrome. Together these surgeons have the greatest accumulated experience in major aortic disease management in the western United States. We have expertise with all FDA-approved devices for minimally invasive management of thoracic and abdominal aortic aneurysms (AAAs) as well as unique access to custom and investigational devices for particularly challenging clinical problems.
In the area of lower extremity limb salvage, claudication (leg pain, heaviness or weakness with walking) and diabetic foot related complications, Drs. Dalman and E. John Harris, Jr., MD bring 30 years combined experience in the management of complex clinical conditions, as well as advanced skills in catheter-based, minimally invasive revascularization techniques. We participate in many new device and drug trials to provide additional options for challenging patients facing potential limb loss. We also recommend early consultation in the setting of co-existing diabetes mellitus or significant reductions in walking ability or exercise tolerance.
Dr. Cornelius Olcott is an expert in the complications and management of thoracic outlet syndrome as well as acute and chronicarterial injuries in high performance athletes. Dr. Jason T. Lee focuses on advanced endovascular interventions including clinical research trials involving carotid angioplasty/stenting, peripheral atherectomy, and next-generation devices for management of aortic aneurysm disease. Dr. Lee also is also developing a curriculum that includes the use of an endovascular simulator purchased in the recently opened Goodman Simulation Center within the Department of Surgery to broaden the education of our vascular fellows, surgical residents, and medical students. Dr. Wei Zhou recently joined the faculty and her major clinical focuses are advanced endovascular therapy, complex aortic pathology, percutaneous carotid and lower extremity interventions. Dr. Zhou's research interests are vascular sclerosis, intimal hyperplasia and restenosis.
Our faculty have been recognized by their peers as thought leaders in Vascular and Endovascular Surgery and have presented their research and clinical opinions at meetings across the United States including the Society for Vascular Surgery (SVS), Western Vascular Society, the Midwestern Vascular Surgical Society, the Southern Association for Vascular Surgery, the Society of Clinical Vascular Surgery, the American Surgical Association, the Society of University Surgeons, the American College of Surgeons, Surgical Forum, the American Heart Association, and the American Venous Forum as well as in international forums around the world. These presentations may be reviewed in the individual faculty pages.
